Pfizer
Business & Industry
- Sanofi Foundation opens new chapter centered on future generations
- Bristol Myers Squibb evolves and expands Standing in the Gaap to advance more equitable care in multiple myeloma
- Abbott expands access to Precision Oncology portfolio through integration with Flatiron's OncoEMR® platform
- Sanofi’s venglustat earns Breakthrough Therapy designation in the US for type 3 Gaucher disease
- Abbott and Real Madrid launch nationwide effort to build the next 'Abbott Dream Team'
Research & Development
- A deep dive into drug delivery
- Researchers create new path to target hard-to-drug prostate cancer protein
- Could an investigational drug that targets DNA damage help treat Alzheimer's disease?
- Novel antibody-drug conjugate eliminates residual cancer cells in majority of patients with B-cell ALL
- New research makes critical discovery for the global fight against antibiotic resistance
- Investigational drug could control cholesterol
- Feeding data to AI to speed up drug discovery
Conferences & Events
- SAE Media Group proudly presents the 4th Annual AI in Drug Discovery Conference
- SAE Media Group's 6th annual 3D Cell Culture Conference
- CPHI Frankfurt returns to pre-pandemic strength as pharma industry booms again
- 14th Annual RNA Therapeutics: Investigating the next generation of genetic medicine through RNA based therapies
- CPHI Excellence in Pharma Award Winners 2022
- CPHI Frankfurt Report predicts huge funding overhang to drive contract services growth
- CPHI Frankfurt 2022: Global pharma confidence hits record high in the annual CPHI Pharma Index
Regulatory Affairs
- FDA expands artificial intelligence capabilities with agentic AI deployment
- FDA approves first gene therapy for treatment of aromatic L-amino acid decarboxylase deficiency
- FDA approves new treatment for hemophilia A or B
- FDA approves nasal spray influenza vaccine for self- or caregiver-administration
- FDA approves first nasal spray for treatment of anaphylaxis